Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

National Healthcare Properties (NHPAP) Long-Term Debt Issuances (2017 - 2024)

National Healthcare Properties has reported Long-Term Debt Issuances over the past 5 years, most recently at $30.3 million for Q3 2024.

For Q3 2024, Long-Term Debt Issuances rose 112.61% year-over-year to $30.3 million; the TTM value through Dec 2025 reached $30.3 million, changed 0.0%, while the annual FY2024 figure was $30.3 million, 87.39% down from the prior year.
Long-Term Debt Issuances for Q3 2024 was $30.3 million at National Healthcare Properties, up from $291000.0 in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $240.0 million in Q4 2023 and troughed at -$240.0 million in Q3 2023.